Cargando…

Putting the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization Into Practice: A Case Series

This case series shows how the 2021 ACC/AHA/SCAI guideline for coronary artery revascularization can be used to decide between revascularization or optimal medical therapy to reduce mortality or cardiovascular events in selected subsets of patients with stable ischemic heart disease and complex coro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bittl, John A., Bangalore, Sripal, DiMaio, J. Michael, Grant, Michael C., Lawton, Jennifer S., Tamis Holland, Jacqueline E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743811/ https://www.ncbi.nlm.nih.gov/pubmed/35036940 http://dx.doi.org/10.1016/j.jaccas.2021.09.025

Ejemplares similares

2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI
por: Don, Creighton W., et al.
Publicado: (2022)

Coronary Artery Bypass Surgery After Transradial Catheterization: Implementing 2021 ACC/AHA/SCAI Revascularization Guidelines Into Clinical Practice
por: Gaudino, Mario, et al.
Publicado: (2021)

The South American Society of Cardiology (SSC) and the Latin American Association of Cardiac and Endovascular Surgery (LACES) Statement on the 2021 ACC/AHA/SCAI Guidelines for Coronary Artery Revascularization
por: Soca, Gerardo, et al.
Publicado: (2023)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

The Japanese Association for Cardiovascular Surgery, The Japanese Association for Thoracic Surgery and The Japanese Association for Coronary Artery Surgery Do Not Endorse Chapter 7.1 in the 2021 ACC/AHA/SCAI Coronary Revascularization Guidelines
por: Yokoyama, Hitoshi, et al.
Publicado: (2022)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
por: Creager, Mark A., et al.
Publicado: (2021)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

TAVR During the COVID-19 Pandemic: The ACC/SCAI Consensus Statement
por: Shreenivas, Satya, et al.
Publicado: (2020)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Chronic Coronary Disease
por: Winchester, David E., et al.
Publicado: (2023)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI
por: Welt, Frederick G.P., et al.
Publicado: (2020)

Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh
por: Rahman, Md. Ashfikur, et al.
Publicado: (2021)

Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
por: Jan, Ya-Ting, et al.
Publicado: (2021)

Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
por: Matyori, Amro, et al.
Publicado: (2023)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline
por: Lee, Ji Hyun, et al.
Publicado: (2018)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

MitraClip for Secondary Mitral Regurgitation: Approach to the 2020 ACC/AHA Valvular Heart Disease Guidelines
por: McCauley, Brian D., et al.
Publicado: (2020)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

Ambulatory Holter monitoring in asymptomatic patients with DDD pacemakers – do we need ACC/AHA Guidelines revision?
por: Chudzik, Michal, et al.
Publicado: (2013)

Overdiagnosis or not? 2017 ACC/AHA high blood pressure clinical practice guideline: Consequences of intellectual conflict of interest
por: Miyazaki, Kei
Publicado: (2018)

Awareness of Physicians and Clinical Pharmacists About ACC/AHA Guidelines for Dyslipidemia Management: A Cross-Sectional Study
por: Zaitoun, Mohammad Fathullah, et al.
Publicado: (2019)

Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017
por: Mirzaei, Mohsen, et al.
Publicado: (2020)

Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines
por: Floyd, Christopher N
Publicado: (2020)

Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management
por: AlAhmad, Mohammad M., et al.
Publicado: (2023)

Stage 1 hypertension defined by the 2017 ACC/AHA blood pressure guideline and cardiometabolic multimorbidity in Chinese adults
por: Qin, Xiaoru, et al.
Publicado: (2023)

ACC/AHA Hypertension Guidelines and CHA(2)DS(2)-VASc Up-Scoring in Patients With Atrial Fibrillation
por: Pundi, Krishna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_08f77lflc5ibs9n0vpoffufk90